How are new technologies changing the world, and what are some of the key emerging risk-related opportunities and challenges?
Moderated by Andrew Maynard, Director, UM Risk Science Center
Gil Omenn, Professor of Internal Professor of Internal Medicine, Human Genetics, and Public Health and Director of the Center for Computational Medicine & Bioinformatics and the Proteomics Alliance for Cancer Research, University of Michigan
James Baker, Ruth Dow Doan Professor of Medicine and Bioengineering, Director of Michigan Nanotechnology Institute for Medicine
Ann Marie Sastry, Arthur F. Thurnau Professor of Mechanical, Biomedical and Materials Science and Engineering, University of Michigan; CEO and Co-Founder of Satki3
Jörg Lahann, Associate Professor of Chemical Engineering, University of Michigan